Literature DB >> 3817872

Clearance kinetics and organ uptake of complement-solubilized immune complexes in mice.

M T Aguado, M Mannik.   

Abstract

C3-bearing immune complexes were prepared by in vitro solubilization of BSA-anti-BSA complexes at equivalence. Sucrose density gradient analyses showed a size-heterogeneous population of solubilized complexes with a range of 7S to greater than 29S and a peak at around 19S. The presence of C3bi was demonstrated by precipitation with antibodies to C3c and to C3d and by binding to conglutinin. Immune complexes solubilized in two and three times antigen excess were selected as controls due to their size similarities with complement-solubilized complexes. Blood clearance curves were very similar for C3-bearing complexes and controls. At 1 hr, the percentage of injected material remaining in the circulation for complement-solubilized and two and three times antigen excess complexes were 29.5 +/- 1.3, 30.9 +/- 1.7 and 26.1 +/- 2.7, respectively. Uptake by liver accounted for the majority of complement- and antigen-solubilized immune complexes removed from circulation. Although the uptake by the spleen was no more than one-tenth of the liver uptake, more complement-solubilized complexes than antigen-solubilized complexes were removed by this organ. The present data indicate that soluble immune complexes bearing C3 components and soluble immune complexes without C3 components, but of comparable size, are cleared from the circulation of mice at comparable rates. The mechanisms of clearance of these two populations of complexes, however, may differ.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3817872      PMCID: PMC1453216     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  23 in total

1.  Purification of bovine conglutinin using pepsin digestion.

Authors:  M A Maire; M Barnet; P H Lambert
Journal:  Mol Immunol       Date:  1981-02       Impact factor: 4.407

2.  Clearance and tissue uptake of immune complexes in complement-depleted and control mice.

Authors:  B Bockow; M Mannik
Journal:  Immunology       Date:  1981-04       Impact factor: 7.397

3.  The binding of complement component C3 to antibody-antigen aggregates after activation of the alternative pathway in human serum.

Authors:  K J Gadd; K B Reid
Journal:  Biochem J       Date:  1981-05-01       Impact factor: 3.857

4.  Interaction of complement solubilized complexes with mouse peritoneal macrophages and their clearance and tissue uptake.

Authors:  N Takahashi; T Fujita; Y Takata; N Tamura
Journal:  Clin Exp Immunol       Date:  1985-07       Impact factor: 4.330

5.  Purification of soluble immune complexes from serum using polymethylmetacrylate beads coated with conglutinin or C1q. Application to the analysis of the components of in vitro formed immune complexes and of immune complexes occurring in vivo during leishmaniasis.

Authors:  P Casali; P H Lambert
Journal:  Clin Exp Immunol       Date:  1979-08       Impact factor: 4.330

6.  Human C4-binding protein. Association with immune complexes in vitro and in vivo.

Authors:  J Scharfstein; E B Correa; G R Gallo; V Nussenzweig
Journal:  J Clin Invest       Date:  1979-03       Impact factor: 14.808

7.  Inhibition of immune precipitation by complement.

Authors:  J A Schifferli; S R Bartolotti; D K Peters
Journal:  Clin Exp Immunol       Date:  1980-11       Impact factor: 4.330

8.  Decreased capacity to solubilize immune complexes in sera from patients with systemic lupus erythematosus.

Authors:  M T Aguado; L H Perrin; P A Miescher; P H Lambert
Journal:  Arthritis Rheum       Date:  1981-10

9.  Studies on antigen-antibody complexes. I. Elimination of soluble complexes from rabbit circulation.

Authors:  M Mannik; M P Arend; A P Hall; B C Gilliland
Journal:  J Exp Med       Date:  1971-04-01       Impact factor: 14.307

10.  Solubilization of immune precipitates by six isolated alternative pathway proteins.

Authors:  T Fujita; Y Takata; N Tamura
Journal:  J Exp Med       Date:  1981-12-01       Impact factor: 14.307

View more
  4 in total

1.  Prolonged circulation of immune complexes due to various altered immune functions contributes to nephritis in MRL/lpr mice.

Authors:  N A Granholm; T Cavallo
Journal:  Clin Exp Immunol       Date:  1990-11       Impact factor: 4.330

2.  Lipopolysaccharide from gram-negative bacteria enhances polyclonal B cell activation and exacerbates nephritis in MRL/lpr mice.

Authors:  T Cavallo; N A Granholm
Journal:  Clin Exp Immunol       Date:  1990-12       Impact factor: 4.330

3.  Immune complex processing in C1q-deficient mice.

Authors:  J T Nash; P R Taylor; M Botto; P J Norsworthy; K A Davies; M J Walport
Journal:  Clin Exp Immunol       Date:  2001-02       Impact factor: 4.330

4.  Malaria inhibits surface expression of complement receptor 1 in monocytes/macrophages, causing decreased immune complex internalization.

Authors:  Cristina Fernandez-Arias; Jean Pierre Lopez; Jean Nikolae Hernandez-Perez; Maria Dolores Bautista-Ojeda; Oralee Branch; Ana Rodriguez
Journal:  J Immunol       Date:  2013-02-25       Impact factor: 5.422

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.